Market Overview

According to fortune business insights, The global cartilage repair market size was valued at USD 1.58 billion in 2025. The market is projected to grow from USD 1.71 billion in 2026 to USD 3.32 billion by 2034, exhibiting a CAGR of 8.7% during the forecast period. North America dominated the global cartilage repair market with a market share of 44.93% in 2025.

The analysis shows that market growth is driven by increasing sports-related injuries, a rising prevalence of osteoarthritis, and advancements in regenerative biologics. Leading companies are focused on continual product development, research, and geographic expansion to maintain their market dominance.

Major Players Profiled in the Market Report:

• Vericel Corporation (U.S.)
• Zimmer Biomet Holdings, Inc. (U.S.)
• Stryker Corporation (U.S.)
• Arthrex, Inc. (U.S.)
• Smith & Nephew plc (U.K.)
• Johnson & Johnson (U.S.)
• Anika Therapeutics, Inc. (U.S.)
• Geistlich Pharma AG (Switzerland)
• MTF Biologics (U.S.)
• AlloSource (U.S.)

Segments

Affordability and Availability to Drive Non-Cell-Based Approaches Segment Growth
Based on treatment, the market is classified into cell-based and non-cell-based approaches. The non-cell-based approaches segment held the highest market share in 2025, as these methods are generally simpler, more affordable, and do not require special laboratories.

Properties of Collagen-based Materials to Accelerate Segment Growth
By material, the market is categorized into collagen-based materials, hyaluronic acid-based materials, hydrogel, and others. The collagen-based materials segment captured the largest share as these materials mimic the body’s natural extracellular matrix, encouraging cell growth and tissue formation.

Substantial Prevalence of Knee Injuries to Accelerate Knee Cartilage Repair Segment Growth
Based on application, the market is segmented into knee, hip, ankle & foot, shoulder, and other cartilage repair. The knee cartilage repair segment holds the largest share (73.9% in 2026) due to the substantial prevalence of knee injuries.

Hospitals & Orthopedic Clinics Segment to Lead Due to High Procedure Volume
By end-user, the market is segmented into hospitals & orthopedic clinics, academic & research institutes, and others. The hospitals & orthopedic clinics segment dominates as these centers have the skilled doctors, advanced tools, and surgical facilities needed to perform complex joint repairs.

Source: https://www.fortunebusinessinsights.com/cartilage-repair-market-114839

Drivers & Restraints

Rising Prevalence of Degenerative Joint Disorders and Sports-Related Injuries to Accelerate Market Growth
The growing prevalence of degenerative joint disorders and an increase in sports-related injuries are set to drive market growth. As the geriatric population increases, the high risk of cartilage degradation is prompting patients and clinicians to seek restorative solutions to delay or avoid total joint replacement.

However, the high cost of cartilage repair procedures, especially those involving advanced cell-based or biologic materials, and limited insurance reimbursement may hamper market growth. These factors can lead patients and hospitals to choose lower-cost alternatives.

Cartilage Repair Market Future Growth:

The market is seeing a prominent trend of shifting from traditional methods toward regenerative solutions that combine cells, scaffolds, and growth factors to rebuild cartilage tissue more effectively. Techniques such as autologous chondrocyte implantation (ACI) and matrix-induced cartilage repair are being adopted more widely. In addition, the increasing use of biologics like Platelet-Rich Plasma (PRP) and stem cells for early-stage cartilage damage offers a substantial non-surgical growth opportunity.

Competitive Landscape

Focus on New Product Launches to Help Companies Maintain Market Position
The market has a semi-concentrated structure, with players such as Vericel Corporation, Zimmer Biomet, and Stryker Corporation dominating. These companies leverage a comprehensive range of regenerative medicines, extensive investments, and strong distribution networks to consolidate their market share. Other players are undertaking various strategic initiatives, such as product innovation and partnerships, to enhance their market presence.

Key Industry Developments

• November 2025: Anika Therapeutics announced the filing of its new candidate, Hyalofast Cartilage Repair Scaffold, for the last phase of its Premarket Approval (PMA) application.
• August 2024: Vericel Corporation announced the introduction of its new product, MACI Arthro, in the U.S.